Open AccessReal-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease
Author(s) -
José María Huguet,
Xavier Cortès,
Marta Maia Boscá-Watts,
M. Aguas,
Nuria Maroto,
Lidia Martí,
Cirilo Amorós,
José María Rubio Paredes
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i36.11285
Subject(s) - medicine , infliximab , biosimilar , ulcerative colitis , context (archaeology) , inflammatory bowel disease , adverse effect , observational study , crohn's disease , clinical trial , disease , gastroenterology , paleontology , biology